A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00001564
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : February 8, 2019
Information provided by:
National Institutes of Health Clinical Center (CC)